RECIDIVA LOCAL DE CÂNCER DE MAMA: RESSECÇÃO DE PAREDE TORÁCICA COM NOVA TÉCNICA DE RECONSTRUÇÃO
Keywords:
Câncer de mama, Recidiva local, Técnica cirúrgicaAbstract
Os autores apresentam uma nova técnica para reconstrução de parede torácica após
ressecção ampla por recidiva local de neoplasia da mama. Quatro pacientes foram submetidas
a ressecção de toda a espessura da parede torácica e a reconstrução realizada através de tela
confeccionada durante o ato operatório com fios de aço 2.0. Não houve complicações pósoperatórias e duas pacientes foram a óbito por doenças sistêmicas 19 e 21 meses após o
procedimento. Duas pacientes se encontram vivas e sem evidência de doença 53 e 61 meses
após a cirurgia.
Downloads
References
1. ANDERSEN J, BLICHERT-TOFT M, DYREBERG U.
In situ carcinomas of the breast. Types, growth pattern,
diagnosis, and treatment. Eur J Surg Oncol 1987; 13:
105-111.
2. ARNESSON LG, SMEDS S, FAGERBERG G,
GRÖNTOFT O. Follow-up to two treatment modalities
for ductal cancer in situ of the breast. Br J Surg 1989;
76: 672-5.
3. BOBROW LG, HAPPERFIELD LC, GREGORY WM
et al. The classification of ductal carcinoma in situ
and its association with biological markers. Semin
Diagn Pathol 1994; 11: 199.
4. CARVALHO FM, ZECCHI DE SOUZA A, BARROS
ACSD et al. Carcinoma mamário não palpável: estudo
radiológico e histológico de 36 casos. X Congresso
Brasileiro de Mastologia, Natal(RN), 18-22 de
setembro de 1995.
5. FISHER ER, CONSTANTINO J, FISHER B et al.
Pathologic findings from the National Surgical
Adjuvant Breast Project (NSABP) Protocol B-17.
Intraductal Carcinoma (Ductal Carcinoma In Situ).
Cancer 1995; 75: 1310-1319.
6. FOOTE FWJR, STEWART FW. Lobular carcinoma in
situ: a rare form of mammary cancer. Am J Pathol
1941; 17: 491-496.7. FOWBLE B. The role of radiotherapy in the treatment of
ductal carcinoma in situ – the challenge of the 1990s.
Breast J 1996; 2: 45-51.
8. FRYKBERG ER, BLAND KI. Overview of the biology
and management of ductal carcinoma in situ of the
breast. Cancer 1994; 74: 350-61.
9. GUMP FE, JICHA DL, OZZELLO L. Ductal carcinoma in
situ (DCIS): a revised concept. Surgery 1987; 102: 790-5.
10.HAAGENSEN C, LANE N, LATLES R, BODIAN C.
Lobular neoplasia (so-called lobular carcinoma - in situ)
of the breast. Cancer 1978; 42: 737-740.
11. HOLLAND R, HENDRICKS JHCL, VEERBEK ALM et
al. Extent, distribution, and mammographical
histological correlations of breast ductal carcinoma in
situ. Lancet 1990; 355: 519-522.
12. HOLLAND R, PETERSE JL, MILLIS RR et al. Ductal
carcinoma in situ: a proposal for a new classification.
Semin Diagn Pathol 1994; 11: 167-180.
13.LAGIOS MD, MARGOLIN FR, WESTDAHL PR,
ROSE MR. Mammographically detected duct
carcinoma “in situ": frequency of local recurrence
following tylectomy and prognostic effect of
nuclear grade on local recurrence. Cancer 1989;
63: 618-24.
14.LAGIOS MD, WESTDAHL PR, MARGOLIN FR, ROSE
MR. Duct carcinoma in situ: relationship of non invasive
disease to the frequency of occult invasion,
multicentricity, lymphnode metastases and short-term
treatment failures. Cancer 1982; 50: 1309-1314.
15.LAGIOS MD. Duct carcinoma in situ. Pathology and
treatment. Surg Clin North Am 1990; 70: 853-871.
16.LEAL CB, SCHMITT FC, BENTO MJ et al. Ductal
carcinoma in situ of the breast. Histologic categorization
and its relationship to ploidy and immunohistochemical
expression of hormone receptors, p52 and c-erb-B2
protein. Cancer 1995; 75: 2123-2131.
17.PAGE DL, DUPONT WD, ROGERS LW et al. Intraductal carcinoma of the breast: follow-up after biopsy
only. Cancer 1982; 49: 751-758.
18. PAGE DL, DUPONT WD, ROGERS LW et al. Atypical
hyperplastic lesions of the female breast: a long-term
follow-up study. Cancer 1985; 55: 2698-2708.
19. РАТCHEFSKY AS, SCHWARTZ GF, FINKELSTEIN SD
et al. Heterogeneity of intraductal carcinoma of the
breast. Cancer 1989; 63: 731-741.
20.POLLER DN, SILVERSTEIN MJ, GALEA M et al.
Ideas in pathology. Ductal carcinoma in situ of the
breast: a proposal for a new simplified histological
classification association between cellular
proliferation and c-erb-B-2 protein expression. Mod
Pathol 1994; 7: 257-262.
21.ROSEN PP, BRAUN DW. The clinical significance of
preinvasive breast carcinoma. Cancer 1980; 46: 919-
925.
22. ROSEN PP, LIEBERMAN PH, BROWN DW JR et al.
Lobular carcinoma – in situ of the breast: detailed
analysis of 99 patients with average follow-up of 24
years. Am J Surg Path 1978; 2: 225-251.
23.SCHNITT SJ, ABNER A, GELMAN R et al. The
relationship between microscopic margins of resection
and the risk of local recurrence in patients with breast
cancer treated with breast-conserving surgery and
radiation therapy. Cancer 1994; 74: 1746-1756.
24.SCHWARTZ GF, FINKELSTEIN GC, GARCIA JC,
PATCHEFSKY AS. Subclinical ductal carcinoma in situ
of the breast. Treatment by local excision and
surveillance alone. Cancer 1992, 70: 2468-2474.
25. SILVERSTEIN MJ, BATH A, POLLER DN et al. Ten
years results comparing mastectomy to excision and
radiation therapy for ductal carcinoma in situ of the
breast. Eur J Cancer 1995; 31A: 1425-1427.
26. SILVERSTEIN MJ, GIERSON ED, COLBURN WJ et al.
Can intraductal breast carcinoma be excised completely
by local excision? Clinical and pathologic predictors.
Cancer 1994; 73: 2985-2989.
27. SILVERSTEIN MJ, LAGIOS MD, GRAIG PH et al. The
Van Nuys prognostic index for ductal carcinoma in situ.
Breast J 1996; 2: 38-40.
28. SILVERSTEIN MH, POLLER DN, WAISMAN JR et al.
Prognostic classification of breast ductal carcinomain-situ. Lancet, 1995; 345: 1154-1997.
29. SILVERSTEIN MJ, WAISMAN JR, GAMAGAMI P et
al. Intraductal carcinoma of the breast (208 cases):
clinical factors influencing treatment choice. Cancer
1990; 66: 102-108.
30. TAVASSOLI FA. Pathology of the breast. Appleton &
Lange, Norwalk, 1992.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Wilmar José Manoel, Carlos Inácio de Paula, Roberto Cesar De Conti, Deidimar Cassia Batista, Sergio Aidar
This work is licensed under a Creative Commons Attribution 4.0 International License.
